Skip to Main Content

Author Details

Ken Dutton-Regester
QIMR Berghofer Medical Research Institute
2011
30
20
PMIDPaper TitleJournal TitlePublished Year
33764308A Virtual Reality Game to Change Sun Protection Behavior and Prevent Cancer: User-Centered Design Approach.JMIR Serious Games2021
33764308A Virtual Reality Game to Change Sun Protection Behavior and Prevent Cancer: User-Centered Design Approach.JMIR Serious Games2021
32249419Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma.Int J Cancer2020
32249419Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma.Int J Cancer2020
32631879News from a postpandemic world.Science2020
32631879News from a postpandemic world.Science2020
29326265The next generation's Frankenstein films.Science2018
29954971Education for the future.Science2018
30287645NextGen Voices: Quality mentoring.Science2018
29301998NextGen VOICES: Research resolutions.Science2018
29326265The next generation's Frankenstein films.Science2018
29954971Education for the future.Science2018
30287645NextGen Voices: Quality mentoring.Science2018
29301998NextGen VOICES: Research resolutions.Science2018
28684488Artificial intelligence in research.Science2017
28467829Whole-genome landscapes of major melanoma subtypes.Nature2017
28684488Artificial intelligence in research.Science2017
28467829Whole-genome landscapes of major melanoma subtypes.Nature2017
26833684The genomic landscape of cutaneous melanoma.Pigment Cell Melanoma Res2016
26833684The genomic landscape of cutaneous melanoma.Pigment Cell Melanoma Res2016
27124452Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.Science2016
27124452Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.Science2016
25243813BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib.Pigment Cell Melanoma Res2015
26304929Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes.Oncotarget2015
26502337Recurrent inactivating RASA2 mutations in melanoma.Nat Genet2015
25243813BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib.Pigment Cell Melanoma Res2015
26304929Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes.Oncotarget2015
26502337Recurrent inactivating RASA2 mutations in melanoma.Nat Genet2015
24008424Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin.J Invest Dermatol2014
25505254Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.J Natl Cancer Inst2014
24008424Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin.J Invest Dermatol2014
24495407Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines.Pigment Cell Melanoma Res2014
24913145A highly recurrent RPS27 5'UTR mutation in melanoma.Oncotarget2014
25070294BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.Eur J Cancer2014
25505254Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.J Natl Cancer Inst2014
25070294BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.Eur J Cancer2014
24913145A highly recurrent RPS27 5'UTR mutation in melanoma.Oncotarget2014
24495407Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines.Pigment Cell Melanoma Res2014
23973372MC1R is a potent regulator of PTEN after UV exposure in melanocytes.Mol Cell2013
23901115Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.Proc Natl Acad Sci U S A2013
23890154Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.Pigment Cell Melanoma Res2013
23973372MC1R is a potent regulator of PTEN after UV exposure in melanocytes.Mol Cell2013
23890154Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.Pigment Cell Melanoma Res2013
23901115Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.Proc Natl Acad Sci U S A2013
22383533A high-throughput panel for identifying clinically relevant mutation profiles in melanoma.Mol Cancer Ther2012
22842228Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.Nat Genet2012
22959033Whole genome and exome sequencing of melanoma: a step toward personalized targeted therapy.Adv Pharmacol2012
22383533A high-throughput panel for identifying clinically relevant mutation profiles in melanoma.Mol Cancer Ther2012
22250051Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene.Genes Chromosomes Cancer2012
22248438Reviewing the somatic genetics of melanoma: from current to future analytical approaches.Pigment Cell Melanoma Res2012
  • 1 - 50 of 60

Recommended Authors

Daniel Cui Zhou
Washington University in St. Louis
Career Start Year 2017
Number of shared co-authors 3
Simone Lubrano
Moores Cancer Center, University of California
Career Start Year 2015
Number of shared co-authors 0
Kerrie L Marie
The University of Manchester
Career Start Year 2015
Number of shared co-authors 4
Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 3
Manoela Tiago
Thomas Jefferson University
Career Start Year 2011
Number of shared co-authors 1
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 1
Mitchell P Levesque
University Hospital Zurich
Career Start Year 2009
Number of shared co-authors 14
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 5
Phil F Cheng
University Hospital of Zurich
Career Start Year 2007
Number of shared co-authors 8
Lawrence N Kwong
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 7
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 7
Heidi V N K??sters-Vandevelde
Canisius Wilhelmina Hospital
Career Start Year 2006
Number of shared co-authors 1
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 3
Mairin Rafferty
Oncomark Ltd.
Career Start Year 2001
Number of shared co-authors 0
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 9
Daniela Mihic-Probst
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 2
Daniel Zingg
Netherlands Cancer Institute
Career Start Year 2001
Number of shared co-authors 1
Nikhil Wagle
Dana-Farber Cancer Institute
Career Start Year 2000
Number of shared co-authors 7
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 5
Carrie Sougnez
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 9
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 12
Cindy Sander
UPMC Hillman Cancer Center
Career Start Year 1997
Number of shared co-authors 3
Andrew E Aplin
Thomas Jefferson University
Career Start Year 1996
Number of shared co-authors 7
Richard W Joseph
Mayo Clinic Hospital
Career Start Year 1994
Number of shared co-authors 3
Ashani T Weeraratna
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Career Start Year 1992
Number of shared co-authors 12
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 12
Dave S B Hoon
Saint John's Cancer Institute at Saint John's Health Center
Career Start Year 1982
Number of shared co-authors 10
Margaret A Tucker
National Cancer Institute
Career Start Year 1976
Number of shared co-authors 7
Meenhard Herlyn
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Career Start Year 1972
Number of shared co-authors 17

Collaborators

Nicholas K Hayward
QIMR Berghofer Medical Research Institute
Co-authored papers 22
Richard A Scolyer
Co-authored papers 6
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 4
Susan L Woods
Adelaide Medical School, University of Adelaide
Co-authored papers 4
Jared J Gartner
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 4
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 3
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Jimmy C Lin
National Human Genome Research Institute, US National Institutes of Health
Co-authored papers 3
Grant A McArthur
University of Melbourne
Co-authored papers 3
Peter Hersey
Co-authored papers 3
Steven E Robinson
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Xiaomu Wei
Cornell University
Co-authored papers 2
Stuart J Gallagher
Co-authored papers 2
David J Adams
Wellcome Sanger Institute
Co-authored papers 2
Guo Chen
China Pharmaceutical University
Co-authored papers 2
Todd D Prickett
National Cancer Institute
Co-authored papers 2
Elliott H Margulies
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 2
Grant W Montgomery
Co-authored papers 2
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 2
Nicholas G Martin
Co-authored papers 2
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Kun-Hsing Yu
Harvard Medical School
Co-authored papers 2
Stephen C J Parker
University of Michigan ann arbor
Co-authored papers 2
Richard B Pearson
Co-authored papers 1
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 1
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 1
Thomas M Keane
European Bioinformatics Institute
Co-authored papers 1
Nobuko Hamasaki-Katagiri
Center for Biologics Evaluation & Research
Co-authored papers 1
Release 1.2